<DOC>
	<DOCNO>NCT00675220</DOCNO>
	<brief_summary>This study conduct Asia . The aim observational study collect efficacy safety data diabetic patient acute hyperglycemia use NovoRapid™ FlexPen™ per normal clinical practice .</brief_summary>
	<brief_title>Observational Study Assess Efficacy Safety NovoRapid™ Flexpen™</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<criteria>Patients diabetes mellitus ( accord product labelling ) Hypoglycaemia Hypersensitivity insulin aspart excipients ( accord product labelling )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>